Gene Z Salkind Cure Pharmaceutical Holding Corp. (CURR) insider trading activity

CURR Quotes by TradingView

Gene Z Salkind is of Cure Pharmaceutical Holding Corp.. Currently has a direct ownership of 117,647 shares of CURR, which is worth approximately $10,588. The most recent transaction as insider was on Sep 23, 2022, when has been sold 117,647 shares (Common Stock) at a price of $0.26 per share, resulting in proceeds of $30,588. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
0% 3M change
0% 12M change
Total Value Held $10,588

Gene Z Salkind Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 23 2022
BUY
Exercise of conversion of derivative security
$30,588 $0.26 p/Share
117,647 Added 50.0%
117,647 Common Stock
Aug 19 2020
BUY
Grant, award, or other acquisition
-
150,000 Added 6.91%
2,021,877 Common Stock
Feb 15 2019
BUY
Grant, award, or other acquisition
-
1,621,877 Added 46.42%
1,871,877 Common Stock
Jan 01 2019
BUY
Grant, award, or other acquisition
-
250,000 Added 50.0%
250,000 Common Stock
GZS

Gene Z Salkind

Oxnard, CA

Track Institutional and Insider Activities on CURR

Follow Cure Pharmaceutical Holding Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CURR shares.

Notify only if

Insider Trading

Get notified when an Cure Pharmaceutical Holding Corp. insider buys or sells CURR shares.

Notify only if

News

Receive news related to Cure Pharmaceutical Holding Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CURR